Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason U Tilan

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cancer|November 13, 2014
Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survivalJason U Tilan, Mark Krailo, Donald A Barkauskas, et al.
The American Journal of Pathology|October 17, 2016
Neuropeptide Y as a Biomarker and Therapeutic Target for NeuroblastomaSusana Galli, Arlene Naranjo, Collin Van Ryn, et al.
Journal of Visualized Experiments : Jove|January 7, 2017
In Vivo Model for Testing Effect of Hypoxia on Tumor MetastasisSung-Hyeok Hong, Jason U Tilan, Susana Galli, et al.
The American Journal of Pathology|September 28, 2011
Impact of fibroblast growth factor-binding protein-1 expression on angiogenesis and wound healingElena Tassi, Kevin McDonnell, Krissa A Gibby, et al.
Oncotarget|February 26, 2015
High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastasesSung-Hyeok Hong, Jason U Tilan, Susana Galli, et al.
Oncotarget|December 10, 2013
Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effectsJason U Tilan, Congyi Lu, Susana Galli, et al.
Oncogene|July 17, 2025
Targeted CRISPR approach reveals an essential role for neuropeptide Y receptor Y5 in Ewing sarcoma extrapulmonary metastasisMina Adnani, Sung-Hyeok Hong, Susana Galli, et al.
Nature Communications|April 28, 2022
Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcomaCongyi Lu, Akanksha Mahajan, Sung-Hyeok Hong, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancer|November 13, 2014
Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survivalJason U Tilan, Mark Krailo, Donald A Barkauskas, et al.
The American Journal of Pathology|October 17, 2016
Neuropeptide Y as a Biomarker and Therapeutic Target for NeuroblastomaSusana Galli, Arlene Naranjo, Collin Van Ryn, et al.
Journal of Visualized Experiments : Jove|January 7, 2017
In Vivo Model for Testing Effect of Hypoxia on Tumor MetastasisSung-Hyeok Hong, Jason U Tilan, Susana Galli, et al.
The American Journal of Pathology|September 28, 2011
Impact of fibroblast growth factor-binding protein-1 expression on angiogenesis and wound healingElena Tassi, Kevin McDonnell, Krissa A Gibby, et al.
Oncotarget|February 26, 2015
High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastasesSung-Hyeok Hong, Jason U Tilan, Susana Galli, et al.
Oncotarget|December 10, 2013
Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effectsJason U Tilan, Congyi Lu, Susana Galli, et al.
Oncogene|July 17, 2025
Targeted CRISPR approach reveals an essential role for neuropeptide Y receptor Y5 in Ewing sarcoma extrapulmonary metastasisMina Adnani, Sung-Hyeok Hong, Susana Galli, et al.
Nature Communications|April 28, 2022
Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcomaCongyi Lu, Akanksha Mahajan, Sung-Hyeok Hong, et al.
Pageof 2